Stephen Gardner

Concepts (105)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lamivudine
11
2012
24
1.320
Why?
Antiviral Agents
9
2013
211
1.140
Why?
Hepatitis B, Chronic
9
2008
19
1.130
Why?
Hepatitis C, Chronic
7
2014
86
1.010
Why?
Hepatitis B e Antigens
7
2008
7
0.660
Why?
Interferon-alpha
2
2013
46
0.520
Why?
Organophosphonates
3
2012
16
0.500
Why?
Adenine
3
2012
46
0.490
Why?
Valine
1
2013
43
0.470
Why?
Ribavirin
1
2013
27
0.470
Why?
Carbamates
1
2013
41
0.470
Why?
Hepacivirus
1
2013
90
0.450
Why?
Polyethylene Glycols
1
2013
149
0.440
Why?
Reverse Transcriptase Inhibitors
7
2005
28
0.400
Why?
Liver Cirrhosis
6
2016
301
0.360
Why?
Hepatitis B Surface Antigens
3
2005
9
0.330
Why?
DNA, Viral
9
2008
114
0.320
Why?
Collagen Type III
2
2016
21
0.280
Why?
Biomarkers
4
2016
1593
0.270
Why?
Alanine Transaminase
8
2008
137
0.260
Why?
Drug Therapy, Combination
5
2013
648
0.260
Why?
Hepatitis B virus
8
2005
23
0.250
Why?
Oxazoles
2
2016
17
0.240
Why?
Tyrosine
2
2016
196
0.220
Why?
Interleukins
3
2012
79
0.220
Why?
Genotype
4
2013
785
0.210
Why?
Liver
4
2014
1118
0.180
Why?
Recombinant Proteins
2
2013
742
0.150
Why?
Adult
14
2014
21375
0.130
Why?
Middle Aged
13
2016
21119
0.130
Why?
Interferons
4
2012
36
0.130
Why?
Double-Blind Method
4
2013
1737
0.130
Why?
Polymorphism, Single Nucleotide
3
2012
627
0.120
Why?
Drug Administration Schedule
2
2013
567
0.120
Why?
Puerto Rico
1
2013
24
0.120
Why?
Viral Nonstructural Proteins
1
2013
16
0.120
Why?
Treatment Outcome
5
2013
7028
0.120
Why?
RNA, Viral
1
2013
93
0.120
Why?
Cholesterol, LDL
2
2012
161
0.110
Why?
Viral Load
1
2013
127
0.110
Why?
Drug Interactions
1
2013
289
0.110
Why?
Male
15
2016
37281
0.110
Why?
Aged
8
2013
14842
0.110
Why?
Fibrosis
1
2014
371
0.110
Why?
Apolipoproteins E
1
2012
92
0.110
Why?
Mutation
3
2008
1213
0.110
Why?
Membrane Transport Proteins
1
2012
81
0.110
Why?
Female
14
2016
38015
0.100
Why?
Humans
19
2016
68525
0.100
Why?
Fatty Liver
1
2011
97
0.090
Why?
Phenotype
1
2013
946
0.090
Why?
Hepatitis B
2
2008
42
0.090
Why?
Cytokines
1
2014
866
0.090
Why?
PPAR gamma
1
2010
95
0.090
Why?
Cohort Studies
4
2014
2356
0.070
Why?
Adolescent
5
2008
8903
0.070
Why?
Hepatitis B Antibodies
2
2004
8
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2014
507
0.060
Why?
United States
2
2013
7335
0.050
Why?
Placebos
1
2002
195
0.050
Why?
Biopsy
2
2014
539
0.050
Why?
Time Factors
2
2005
4655
0.040
Why?
Quinazolines
1
2016
70
0.040
Why?
Thiazolidinediones
1
2016
76
0.040
Why?
Predictive Value of Tests
2
2014
1465
0.040
Why?
Disease Progression
2
2014
1037
0.040
Why?
Blood Chemical Analysis
1
2014
43
0.030
Why?
Histocytochemistry
1
2014
149
0.030
Why?
Extracellular Matrix Proteins
1
2014
144
0.030
Why?
Hong Kong
1
2012
11
0.030
Why?
Tablets
1
2012
19
0.030
Why?
Therapeutic Equivalency
1
2012
21
0.030
Why?
Metabolic Clearance Rate
1
2012
48
0.030
Why?
Capsules
1
2012
18
0.030
Why?
Half-Life
1
2012
96
0.030
Why?
Biological Availability
1
2012
79
0.030
Why?
Apolipoprotein C-I
1
2012
2
0.030
Why?
Apolipoproteins B
1
2012
29
0.030
Why?
Patient Selection
1
2016
592
0.030
Why?
Safety
2
2003
145
0.030
Why?
Area Under Curve
1
2012
238
0.030
Why?
Cross-Over Studies
1
2012
260
0.030
Why?
Drug Combinations
1
2012
304
0.030
Why?
Administration, Oral
1
2012
411
0.030
Why?
Multivariate Analysis
1
2014
1046
0.030
Why?
Dyslipidemias
1
2012
98
0.030
Why?
Lipoproteins
1
2011
161
0.020
Why?
Genetic Association Studies
1
2010
103
0.020
Why?
Lipid Metabolism
1
2011
186
0.020
Why?
Prognosis
1
2014
2093
0.020
Why?
Genetic Predisposition to Disease
1
2011
785
0.020
Why?
Child, Preschool
2
2004
3185
0.020
Why?
Drug Resistance, Viral
1
2003
14
0.020
Why?
Amino Acid Motifs
1
2004
77
0.010
Why?
Retreatment
1
2003
59
0.010
Why?
Viral Proteins
1
2004
149
0.010
Why?
Necrosis
1
2003
239
0.010
Why?
Child
2
2004
6400
0.010
Why?
Genetic Variation
1
2003
220
0.010
Why?
Young Adult
1
2012
5708
0.010
Why?
Longitudinal Studies
1
2003
1054
0.010
Why?
Logistic Models
1
2002
1419
0.010
Why?
Follow-Up Studies
1
2002
3256
0.010
Why?
Prospective Studies
1
2003
3702
0.010
Why?
Retrospective Studies
1
2003
7264
0.010
Why?
Gardner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (105)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_